Tangdu Hospital, the Air Force Military University
Welcome,         Profile    Billing    Logout  
 0 Trials 
7 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
yan, xiaolong
TERMGGO, NCT04982900: Treatment of EGFR-TKI for Residual Lesions of Multiple Synchronous Ground-glass Opacities

Recruiting
2
138
RoW
furmonertinib, AST2818, Placebo
Ruijin Hospital, Fujian Medical University Union Hospital, First Affiliated Hospital of Zhejiang University, Second Affiliated Hospital, School of Medicine, Zhejiang University, Tang-Du Hospital, The First Affiliated Hospital of Nanchang University
Multiple Primary Lung Cancers
08/22
08/22
NCT05400070: Neoadjuvant PD-1 Inhibitor (Sintilimab), Anlotinib Combined With Chemotherapy in Resectable Stage IIA-IIIB NSCLC

Active, not recruiting
2
45
RoW
Neoadjuvant therapy 1, anlotinib 10mg, po, qd1-14, q3w, Chemotherapy, Sintilimab (200mg fixed dose) iv, d1, q3w
Tang-Du Hospital
Sintilimab, Lung Cancer, Anlotinib, Chemotherapy
12/23
12/26
NO.202405-11, NCT06475755: Neoadjuvant/Adjuvant Tislelizumab Combined With Anlotinib and Platinum Doublet Chemotherapy With Resectable NSCLC

Not yet recruiting
2
178
RoW
Immunochemotherapy combined with antiangiogenic, Tislelizumab, Anlotinib, Cisplatin, Carboplatin, Paclitaxel, Albumin-bound paclitaxel, Pemetrexed, Immunochemotherapy
Tang-Du Hospital
Non-Small Cell Lung Cancer, Anti Angiogenesis
06/25
12/27
NCT06485544: Neoadjuvant Adebrelimab in Resectable SCLC: A Randomized Trial

Recruiting
2
104
RoW
Adebrelimab + Etoposide + Platinum-based Therapy, Etoposide + Platinum-based Therapy
Tang-Du Hospital
Small Cell Lung Cancer (SCLC)
12/25
12/26
NCT06006650: Neoadjuvant Therapy for Stage II-IVA Resectable Esophageal Squamous Cell

Recruiting
2
114
RoW
Pembrolizumab, Albumin Paclitaxel, 5-fluorouracil, Cisplatin
Tang-Du Hospital
Neoadjuvent, PD-1 Inhibitor, Chemotherapy, Esophageal Squamous Cell Carcinoma
12/31
12/31
NCT06644066: Partial Pressure of Oxygen Control Method in Identification of Intersegmental Plane

Recruiting
N/A
60
RoW
Partial pressure of Oxygen Control method
Tang-Du Hospital
Lung Cancer
07/24
12/24
NCT06028412: Comparison of Sublobar and Lobectomy in Small (2 Cm or Less 0.5

Enrolling by invitation
N/A
660
RoW
Sublobar, Lobectomy
Xiaolong Yan, Dr.
NSCLC, Stage I
12/29
12/30

Download Options